Early antiretroviral therapy

Abstract
Aim To review evidence suggesting that antiretroviral therapy should be initiated at an early stage in HIV infection. Method Review of published data. Conclusions There are arguments both for and against early antiretroviral therapy. Although the reasons against are undoubtedly valid, evidence of greater efficacy, less toxicity and a delay in the development of resistance outweigh the possible disadvantages. Moreover, for some patients, early therapy may provide a chance of future benefits from more useful but currently untried treatments.

This publication has 0 references indexed in Scilit: